JP2021525707A5 - - Google Patents

Info

Publication number
JP2021525707A5
JP2021525707A5 JP2020565771A JP2020565771A JP2021525707A5 JP 2021525707 A5 JP2021525707 A5 JP 2021525707A5 JP 2020565771 A JP2020565771 A JP 2020565771A JP 2020565771 A JP2020565771 A JP 2020565771A JP 2021525707 A5 JP2021525707 A5 JP 2021525707A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
spinal cord
cord injury
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020565771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/033303 external-priority patent/WO2019226643A1/en
Publication of JP2021525707A publication Critical patent/JP2021525707A/ja
Publication of JP2021525707A5 publication Critical patent/JP2021525707A5/ja
Withdrawn legal-status Critical Current

Links

JP2020565771A 2018-05-25 2019-05-21 脊髄損傷を処置するための方法 Withdrawn JP2021525707A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862676464P 2018-05-25 2018-05-25
US62/676,464 2018-05-25
PCT/US2019/033303 WO2019226643A1 (en) 2018-05-25 2019-05-21 Methods for treating spinal cord injury

Publications (2)

Publication Number Publication Date
JP2021525707A JP2021525707A (ja) 2021-09-27
JP2021525707A5 true JP2021525707A5 (cg-RX-API-DMAC7.html) 2022-05-30

Family

ID=68616947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565771A Withdrawn JP2021525707A (ja) 2018-05-25 2019-05-21 脊髄損傷を処置するための方法

Country Status (8)

Country Link
US (1) US20210254101A1 (cg-RX-API-DMAC7.html)
EP (1) EP3801482A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021525707A (cg-RX-API-DMAC7.html)
KR (1) KR20210050493A (cg-RX-API-DMAC7.html)
CN (1) CN112752573A (cg-RX-API-DMAC7.html)
AU (1) AU2019274481A1 (cg-RX-API-DMAC7.html)
CA (1) CA3100902A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019226643A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US20180272132A1 (en) 2017-01-19 2018-09-27 Nevro Corp. High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods
RS64823B1 (sr) * 2020-03-13 2023-12-29 Astrazeneca Ab Fuzionisana pirimidinska jedinjenja kao modulatori kcc2
CN111388654A (zh) * 2020-05-22 2020-07-10 南通大学 治疗脊髓损伤的药物、药物试剂盒及方法
RU2758760C1 (ru) * 2021-01-22 2021-11-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Казанский Государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ лечения травматического повреждения спинного мозга
CN114107231B (zh) * 2021-12-13 2023-08-18 重庆大学 实现全脑突触后神经元胞体标记的重组腺相关病毒及其应用
CN116286917A (zh) * 2021-12-14 2023-06-23 中国科学院深圳先进技术研究院 重组载体及其构建方法和应用
WO2023108405A1 (zh) * 2021-12-14 2023-06-22 中国科学院深圳先进技术研究院 重组载体及其构建方法和应用
AU2023299284A1 (en) * 2022-07-01 2025-01-16 Nevro Corp. Neurostimulation for treating sensory deficits, and associated systems and methods
CN115317614B (zh) * 2022-10-14 2022-12-27 暨南大学 Adk抑制剂在制备治疗脊髓损伤的药物中的应用
CN120699131B (zh) * 2024-12-04 2025-12-09 良渚实验室 治疗帕金森病的化学遗传学基因治疗新方案
CN121401191A (zh) * 2025-12-12 2026-01-27 山东大学齐鲁医院 一种通过重塑残存神经环路介导脊髓损伤修复的核酸凝胶及其构建方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2387082T3 (es) * 2001-05-17 2012-09-13 Merck Serono Sa Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas
US7709207B2 (en) * 2003-05-16 2010-05-04 Universite Laval Method for identifying compounds for treatment of pain
KR100519693B1 (ko) * 2003-12-12 2005-10-13 한국과학기술연구원 α1G T-형 칼슘 채널 활성 연구 및 고효율 억제제 검색용 HEK293 세포주
WO2007081521A2 (en) * 2006-01-05 2007-07-19 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
EP2389371A4 (en) * 2009-01-22 2012-09-12 Neurotherapeutics Pharma Inc ANALOGUES OF BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE AND TORSEMID, AND RELATED COMPOSITIONS AND METHODS OF USE
US8812115B2 (en) * 2009-07-10 2014-08-19 Boston Scientific Neuromodulation Corporation System and method for reducing excitability of dorsal root fiber by introducing stochastic background noise
JP5914357B2 (ja) * 2010-01-15 2016-05-11 インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) 自閉症の治療のための化合物
EP2732815A1 (en) * 2012-11-16 2014-05-21 Neurochlore Modulators of intracellular chloride concentration for treating fragile X syndrome
WO2015135947A1 (en) * 2014-03-10 2015-09-17 Universite D'aix-Marseille Piperazine phenothiazine derivatives for treating spasticity
EP3426307B1 (en) * 2016-03-09 2023-09-06 Assaf, Fadi Using dreadd for neuronal modulation in treating neuronal diseases
US20190046662A1 (en) * 2016-03-24 2019-02-14 Rutgers, The State University Of New Jersey Compositions and Methods for Treating Neuropathic Pain
AU2017321708B2 (en) * 2016-08-31 2024-01-04 Rutgers, The State University Of New Jersey Methods and compositions for treating diseases and disorders of the nervous system

Similar Documents

Publication Publication Date Title
US11873505B2 (en) Compositions and methods for regulating production of a precursor protein
EP3116508A1 (en) Combined use of a vector encoding a modified receptor and its exogenous agonist in the treatment of seizures
JP2021525707A (ja) 脊髄損傷を処置するための方法
US20220241325A1 (en) Antioxidant and antiviral compositions and methods
JP2018517704A (ja) 筋萎縮性側索硬化症(ALS)を処置するためのmiR−155阻害剤
RU2593948C2 (ru) Способ ингибирования репликации вич в клетках млекопитающих и у людей
US20160108431A1 (en) Prevention and treatment of atrial fibrillation
WO2022061112A1 (en) Combination treatment for cancer
US20180291377A1 (en) Blood Brain Barrier Opening Agents and Uses Thereof
US20220154183A1 (en) CHMP2A as a Regulator of Natural Killer Cell-Mediated Activity
US10537591B2 (en) Method for promoting muscle regeneration
JP2022552378A5 (cg-RX-API-DMAC7.html)
JP2025527176A (ja) リンパ浮腫を処置するためのアペリンの使用
WO2023240225A1 (en) Constitutively active polymeric sting mimics for antitumor immunity
KR20240159829A (ko) 면역계를 조정하기 위한 조성물 및 방법
US8686127B2 (en) Apoptosis inducer
CN114245749A (zh) 基于REIC/Dkk-3基因与抗肿瘤剂的联用的肝癌的治疗方法
US12612627B2 (en) Compositions and methods for increasing sodium current in cardiac cells
US20250215403A1 (en) Compositions and Methods for Cardiac Tissue Regeneration
US11230711B2 (en) Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke
US8361985B2 (en) Short hairpin RNA for gene knockdown of NR1 subunit of the N-methyl-D-aspartate receptor and its application on pharmaceutics
WO2025166047A1 (en) Composition and method for preventing or treating influenza
Li et al. TUG1 suppresses neural repair subsequent to cerebral hemorrhage via the miR-381-3p/BDNF axis
WO2025238184A1 (en) Scn10a-short gene therapy to restore cardiac impulse conduction and to protect against cardiac arrhythmia
US9885044B2 (en) Polynucleotides and methods for inhibiting cancer cells